Therefore, TrkA/CD44v3 complex formation was assessed in breast cancer tissue microarrays to determine the level to which it correlated with clinical-biological parameters of breast tumors (i.e., estrogen receptor, PR and HER2 expression) (Fig. 7E & F). This evidence concerns the gene ESR1 and breast carcinoma.